Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)
Email verificata su salford.ac.uk
Citato da 121749
Senescence Mitochondria Cancer Stem Cells Breast Cancer Drug Discovery
Andrew Sloan, MD, FACS

Andrew Sloan, MD, FACS

Piedmont Health & Case Western Reserve University School of Medicine
Email verificata su Piedmont.org
Citato da 68456
brain tumor glioma epidemiology Cancer stem cells Immunotherapy
Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh
Email verificata su upmc.edu
Citato da 65747
Neuro-Oncology stem cell biology brain tumors cancer stem cells neurooncology
Luis F. Parada

Luis F. Parada

Director, Brain Tumor Center, Memorial Sloan Kettering Cancer Center
Email verificata su mskcc.org
Citato da 56834
cancer stem cells neurogenesis mouse models glioblastoma neurofibromatosis
Saverio Minucci

Saverio Minucci

European Institute of Oncology and University of Milan
Email verificata su ieo.it
Citato da 44880
cancer epigenetics cancer stem cells
Gennaro Ciliberto

Gennaro Ciliberto

Istituto Nazionale Tumori "Regina Elena" Roma
Citato da 39511
Cancer Immunotherapy Drug Resistance Cancer stem Cells
Gil Mor

Gil Mor

Yale University/Wayne State University
Email verificata su med.wayne.edu
Citato da 38674
reproductive immunology cancer stem cells inflammation
Christopher Heeschen

Christopher Heeschen

Candiolo Cancer Institute - FPO - IRCCS
Email verificata su ircc.it
Citato da 38548
Cancer stem cells Pancreatic cancer Niche Microenvironment
James Till

James Till

Professor Emeritus, University of Toronto
Email verificata su uhnres.utoronto.ca
Citato da 34615
Current: Open Access Cancer Stem Cells
Sendurai A. Mani

Sendurai A. Mani

Associate Director for Translational Oncology, Legorreta Cancer Center at Brown University
Email verificata su brown.edu
Citato da 34192
cancer biology metastasis cancer stem cells EMT chemoresistance
1 - 10